INGN
Inogen Inc
NASDAQ · Healthcare · Medical - Devices · US
$7.22
+2.85%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$7.20
From 52W high−10.42%
Volume289497.00
Market cap$191.61M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataNov 4, 2026
Open
$7.20
From 52W high
−10.42%
Volume
289497.00
Market cap
$191.61M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−18.7x
P/E (TTM)
—
RSI (14)
68.9
MomentumView details →
1D Return
+2.85%
YTD Return
+7.70%
SummaryUpdated Jun 1, 2026
Inogen, Inc. (NASDAQ:INGN) is a medical technology company founded in 2001 and headquartered in Goleta, California. The company went public in February 2014 and specializes in developing, manufacturing, and marketing portable oxygen concentrators and related respiratory medical devices. Inogen serves patients with chronic respiratory conditions who require supplemental oxygen therapy, operating primarily in the United States with expanding international presence. The company has evolved from a pure-play portable oxygen concentrator manufacturer to a broader respiratory care solutions provider, recently expanding its product portfolio through acquisitions and new product development.
Similar companies
Latest newsMore news →
Inogen Inc announced that it will report its third-quarter 2026 financial results on November 5, 2026.20d agoInogen Inc amended its share repurchase program, increasing the aggregate authorization from $30.0 million to $45.0 million and extending the expiration date to June 30, 2028, conditioned on closing of the asset purchase agreement.35d agoInogen Inc signed a product supply agreement with Rotech Healthcare Inc.35d ago